1. Home
  2. THR vs EOLS Comparison

THR vs EOLS Comparison

Compare THR & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THR
  • EOLS
  • Stock Information
  • Founded
  • THR 1954
  • EOLS 2012
  • Country
  • THR United States
  • EOLS United States
  • Employees
  • THR N/A
  • EOLS N/A
  • Industry
  • THR Industrial Machinery/Components
  • EOLS Biotechnology: Pharmaceutical Preparations
  • Sector
  • THR Energy
  • EOLS Health Care
  • Exchange
  • THR Nasdaq
  • EOLS Nasdaq
  • Market Cap
  • THR 960.7M
  • EOLS 787.7M
  • IPO Year
  • THR 2011
  • EOLS 2018
  • Fundamental
  • Price
  • THR $31.19
  • EOLS $13.04
  • Analyst Decision
  • THR Strong Buy
  • EOLS Strong Buy
  • Analyst Count
  • THR 1
  • EOLS 6
  • Target Price
  • THR $38.00
  • EOLS $22.60
  • AVG Volume (30 Days)
  • THR 222.1K
  • EOLS 676.4K
  • Earning Date
  • THR 11-07-2024
  • EOLS 11-06-2024
  • Dividend Yield
  • THR N/A
  • EOLS N/A
  • EPS Growth
  • THR 4.78
  • EOLS N/A
  • EPS
  • THR 1.29
  • EOLS N/A
  • Revenue
  • THR $493,855,000.00
  • EOLS $248,326,000.00
  • Revenue This Year
  • THR $7.99
  • EOLS $33.57
  • Revenue Next Year
  • THR $7.58
  • EOLS $32.91
  • P/E Ratio
  • THR $24.24
  • EOLS N/A
  • Revenue Growth
  • THR 3.94
  • EOLS 34.42
  • 52 Week Low
  • THR $23.76
  • EOLS $9.29
  • 52 Week High
  • THR $35.93
  • EOLS $17.82
  • Technical
  • Relative Strength Index (RSI)
  • THR 68.30
  • EOLS 38.46
  • Support Level
  • THR $29.79
  • EOLS $11.88
  • Resistance Level
  • THR $30.96
  • EOLS $12.67
  • Average True Range (ATR)
  • THR 1.22
  • EOLS 0.74
  • MACD
  • THR 0.35
  • EOLS -0.16
  • Stochastic Oscillator
  • THR 93.62
  • EOLS 27.51

About THR Thermon Group Holdings Inc.

Thermon Group Holdings Inc is a United States-based company that provides engineered thermal solutions for process industries. The company's product portfolio comprises electric heat tracing cables, steam tracing components, tubing bundles, and instrument and control products, as well as complementary product lines. It also provides turnkey services and design and engineering services. The company's customers include large engineering, procurement, and construction companies; oil and gas companies; commercial subcontractors; electrical component distributors; and others. The company has a presence, with the United States, Canada, and Europe being its top three markets and contributing the majority of its sales.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the cash-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications. It generates product revenue from the sale of Jeuveau in the United States and Europe, and service revenue from distribution partners in Canada.

Share on Social Networks: